Moderna (MRNA) PT Lowered to $140 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
BofA expresses concerns about Moderna (MRNA) guidance, which 'may be a high bar'
April 12, 2023 11:24 AM EDTBofA was left with more questions than answers following Moderna's (NASDAQ: MRNA) Vaccines Day, analyst Geoff Meacham told investors in a note Wednesday.
The analyst, who has a Neutral rating and $200 price target on Moderna, said the firm "wouldn't be surprised if shares... More



